This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US states oppose Florida price-fixing settlement’s MFN clause with drugmakers

( March 17, 2025, 21:28 GMT | Official Statement) -- MLex Summary: Twenty states, the District of Columbia and the US Virgin Islands objected to a most favored nation clause included in a generic drug price-fixing settlement between the Florida Attorney General, Sandoz, Novartis and others. “Through this provision, the proposed settlement places an arbitrary, diminished value on the claims of the rest of the States with no corresponding benefit and has the practical effect of significantly delaying or preventing a settlement between the States and Settling Defendants for almost four years, despite the current stage of litigation,” the states said in an opposition filed with the District of Connecticut.See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections